Coya Therapeutics COYA Ratios (2022-2026)

NASDAQ COYA
$3.21 +0.05 (+1.58%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Coya Therapeutics Quarterly Ratios

Periods 19 quarters
Latest Sep 2026

Coya Therapeutics reported a net margin of -4,534,899,245.73% for the quarter ended Sep 2026. These financial ratios cover 19 quarters of results from Mar 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
EBT Margin 30.24%-3,982.96%-84.42%-209,031.51%-2,833.35%-3,725.17%-59.36%-144.08%-2,869.63%-2,723.44%-4,534.90%
EBIT Margin 30.24%-4,322.84%-94.48%-209,031.51%-2,976.89%-3,920.47%-68.26%-152.30%-3,042.13%-2,891.13%-4,676.21%
EBITDA Margin 30.36%-4,317.45%-94.28%-208,681.10%-2,974.24%-3,916.29%-68.07%-152.12%-3,041.01%-2,889.98%-4,675.01%
Operating Margin 30.24%-4,322.84%-94.48%-209,031.51%-2,976.89%-3,920.47%-68.26%-152.30%-3,042.13%-2,891.13%-4,676.21%
Net Margin 21.09%-3,982.96%-84.42%-149,373.77%-2,833.35%-3,725.17%-59.36%-144.16%-2,869.63%-2,723.44%-4,534,899,245.73%
FCF Margin -37.34%1,691.82%-133.23%-123,451.18%-1,096.72%-3,528.56%-31.72%-25.43%-2,472.07%-3,026.08%-3,090.19%
Efficiency
Assets AverageAssets Avg. 12.91M15.94M13.18M26.58M39.33M38.67M37.75M39.95M41.38M35.93M32.75M41.00M51.61M50.29M43.31M
Equity AverageEquity Avg. 2.80M0.28M-3.38M-6.88M3.88M14.70M11.67M22.86M34.01M33.82M33.63M35.79M36.47M30.84M27.80M35.16M46.00M46.12M38.42M
Asset Utilization RatioAsset Util. 0.230.160.250.250.090.090.010.120.190.150.160.11
Valuation
Price to SalesP/S 12.5523.659.6510.2826.9429.36227.1123.9312.2111.6417.1125.06
Price to BookP/B 2.453.063.792.114.482.623.072.423.243.403.502.261.893.173.50
Enterprise Value 6.34M23.17M27.39M27.31M42.69M108.96M55.64M67.08M57.39M72.68M66.37M67.30M50.21M41.70M94.03M81.72M
Market Capitalization 12.28M39.49M40.49M38.20M75.31M144.96M92.24M98.18M95.73M108.21M96.17M95.43M97.04M92.42M137.23M117.52M
Return Ratios
Return on Sales [ROS]ROS 30.24%-4,322.84%-94.48%-118.84%-209,031.51%-2,976.89%-3,920.47%-68.26%-152.30%-3,042.13%-2,891.13%-4,676.21%
Return on Capital Employed [ROCE]ROCE -94.60%-73.49%-103.04%-36.71%-29.95%-30.05%-32.05%-47.75%-52.50%-71.98%-70.85%-64.21%-46.85%-49.49%-83.51%
Return on Assets [ROA]ROA -85.31%-67.86%-88.92%-29.74%-25.57%-25.07%-28.03%-41.24%-45.27%-61.04%-59.84%-51.77%-40.93%-43.08%-69.65%
Return on Equity [ROE]ROE -283.85%-73.60%-100.46%-34.57%-29.56%-28.65%-31.45%-46.03%-51.35%-71.12%-70.50%-60.37%-45.92%-46.98%-78.52%

Coya Therapeutics Ratios API

Pull Coya Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=COYA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY